Molecule glue drugs shake up cancer care, draw big money

Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therapies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l5uhT37
via IFTTT